Healthcare & Life Sciences
Eradivir
United Stateseradivir.com
Eradivir is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Eradivir
Based in the United States, Eradivir is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Eradivir develops small molecule therapies using its Bispecific Antigenic immuno-Therapy (BAiT™️) technology to target and flag diseased cells and viruses, enabling immune system clearance, with a focus on treating viral infections such as influenza.
Explore Eradivir's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.